ADAR1 Capital Management Calls For Keros Therapeutics To Restructure Business, Reduce Headcount

May 8 (Reuters) - ADAR1 Capital Management:

• ADAR1 CAPITAL MANAGEMENT: CALLS FOR KEROS TO RESTRUCTURE BUSINESS, SIGNIFICANTLY REDUCE HEADCOUNT, RETURN EXCESS CAPITAL TO STOCKHOLDERS

• ADAR1 CAPITAL MANAGEMENT: TO "WITHHOLD" VOTES ON RE-ELECTION OF MARY ANN GRAY & ALPNA SETH AT KEROS THERAPEUTICS' ANNUAL MEETING OF STOCKHOLDERS

• ADAR1 CAPITAL MANAGEMENT: URGED KEROS TO DISCONTINUE DEVELOPMENT OF KER-012 AND KER-065